Russell Frank Company’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$221K Sell
13,152
-16,412
-56% -$289K ﹤0.01% 2656
2015
Q4
$668K Sell
29,564
-50,018
-63% -$1.03M ﹤0.01% 2387
2015
Q3
$1.74M Sell
79,582
-84,453
-51% -$2.11M ﹤0.01% 1932
2015
Q2
$4.04M Buy
164,035
+72,653
+80% +$1.62M 0.01% 1553
2015
Q1
$1.87M Buy
+91,382
New +$1.77M ﹤0.01% 1811
2014
Q3
Sell
-38,166
Closed -$629K 2848
2014
Q2
$629K Sell
38,166
-3,976
-9% -$66.2K ﹤0.01% 2249
2014
Q1
$669K Buy
42,142
+9,380
+29% +$192K ﹤0.01% 2262
2013
Q4
$675K Buy
32,762
+32,649
+28,893% +$475K ﹤0.01% 2229
2013
Q3
$1K Buy
113
+27
+31% +$266 ﹤0.01% 3382
2013
Q2
$1K Buy
+86
New +$749 ﹤0.01% 3211

Other funds holding ATRC

Russell Frank Company's ATRC Position: Q1 2016 in Review

Russell Frank Company reduced its AtriCure (ATRC) stake by 56% in Q1 2016, selling an estimated $289K and leaving 13,152 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Russell Frank Company first reported a position in ATRC in Q2 2013 and has held it in 10 quarters since. The position peaked at $4.04M in Q2 2015. 113 funds tracked by Wall St. Rank hold ATRC as of Q1 2016.

  • Russell Frank Company held 13,152 shares of AtriCure worth $221K as of Q1 2016.
  • Russell Frank Company sold 16,412 AtriCure shares in Q1 2016, an estimated $289K.
  • AtriCure made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2656 holding.
  • Russell Frank Company first reported a position in AtriCure in Q2 2013 and has held it in 10 quarters since.
  • Russell Frank Company's AtriCure position peaked at $4.04M in Q2 2015.
  • 113 funds tracked by Wall St. Rank held AtriCure as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.